MedTrace Logo

Clinical Outcomes of Post-placental Insertion of Cupper T380A and Multiload 375 Contraceptive Devices During Cesarean Section

NCT05624411 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 150

Last updated 2022-11-22

No results posted yet for this study

Summary

Clinical outcomes of post-placental insertion of Cupper T380A and Multiload 375 contraceptive devices during cesarean section

Conditions

  • IUD (Intrauterine Device) Malposition
  • IUD; Complications, Infection or Inflammation

Interventions

DEVICE

CU T380A IUD

post-placental insertion of intrauterine contraceptive device

DEVICE

multiload 375 IUD

post-placental insertion of intrauterine contraceptive device

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-22
Primary Completion
2023-09-01
Completion
2023-09-01
FDA Device
Yes

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05624411 on ClinicalTrials.gov